Wnt/β-catenin信号通路与肿瘤干细胞

摘要/Abstract

摘要：成体干细胞在机体组织再生中发挥重要作用，在发生恶性转化时形成肿瘤干细胞。肿瘤干细胞与多种肿瘤的发生、化疗抵抗和复发密切相关。Wnt/βcatenin信号通路调控胚胎发育，进化高度保守，在肿瘤干细胞的自我更新和分化过程中发挥重要作用。Wnt/βcatenin信号通路及相关调节蛋白逐渐成为肿瘤干细胞靶向治疗的热门靶标。

关键词:肿瘤干细胞,治疗,Wnt/β-catenin信号通路

Abstract:Adult stem cells play important roles in the regeneration of human tissues, and they form cancer stem cells when malignant transformation occurs. Cancer stem cells are closely related to the occurrence of various tumors, chemotherapy resistance and recurrence. The Wnt/βcatenin signaling pathway regulates embryonic development and is evolutionarily conserved, and plays an important role in selfrenewal and differentiation of cancer stem cells. The Wnt/βcatenin signaling pathway and related regulatory proteins have become a hot target for cancer stem cell targeted therapy.

Key words:Neoplastic stem cells,Therapy,Wnt/β-catenin signaling pathway

郑佩. Wnt/β-catenin信号通路与肿瘤干细胞[J]. 国际肿瘤学杂志, 2017, 44(11): 853-855.

郑佩. Wnt/β-catenin signaling pathway and cancer stem cells[J]. Journal of International Oncology, 2017, 44(11): 853-855.

参考文献

［1］ Lenz HJ, Kahn M. Safely targeting cancer stem cells via selective catenin coactivator antagonism［J］. Cancer Sci, 2014, 105(9): 1087-1092. DOI: 10.1111/cas.12471. ［2］Li Y, Zhang T. Targeting cancer stem cells by curcumin and clinical applications［J］. Cancer Lett, 2014, 346(2): 197-205. DOI: 10.1016/j.canlet.2014.01.012. ［3］Voronkov A, Krauss S. Wnt/betacatenin signaling and small molecule inhibitors［J］. Curr Pharm Des, 2013, 19(4): 634-664. ［4］Lamb R, Ablett MP, Spence K, et al. Wnt pathway activity in breast cancer subtypes and stemlike cells［J］. PLos One, 2013, 8(7): e67811. DOI: 10.1371/journal.pone.0067811. ［5］Cai WY, Wei TZ, Luo QC, et al. The Wntβcatenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion［J］. J Cell Sci, 2013, 126(Pt 13): 2877-2889. DOI: 10.1242/jcs.123810. ［6］Zhao Z, Lu P, Zhang H, et al. Nestin positively regulates the Wnt/βcatenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells［J］. Breast Cancer Res, 2014, 16(4): 408. DOI: 10.1186/s1305801404088. ［7］Fu Y, Chang H, Peng X, et al. Resveratrol inhibits breast cancer stemlike cells and induces autophagy via suppressing Wnt/βcatenin signaling pathway［J］. PLoS One, 2014, 9(7): e102535. DOI: 10.1371/journal.pone.0102535. ［8］Jang GB, Hong IS, Kim RJ, et al. Wnt/βcatenin smallmolecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stemlike cells［J］. Cancer Res, 2015, 75(8): 1691-1702. DOI: 10.1158/00085472.CAN-14-2041. ［9］Krausova M, Korinek V. Wnt signaling in adult intestinal stem cells and cancer［J］. Cell Signal, 2014, 26(3): 570579. DOI: 10.1016/j.cellsig.2013.11.032. ［10］ Roy S, Majumdar AP. Signaling in colon cancer stem cells［J］. J Mol Signal, 2012, 7(1): 11. DOI: 10.1186/17502187711. ［11］ Kemper K, Prasetyanti PR, De Lau W, et al. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells［J］. Stem Cells, 2012, 30(11): 2378-2386. DOI: 10.1002/stem.1233. ［12］ Moon BS, Jeong WJ, Park J, et al. Role of oncogenic KRas in cancer stem cell activation by aberrant Wnt/βcatenin signaling［J］. J Natl Cancer Inst, 2014, 106(2): djt373. DOI: 10.1093/jnci/djt373. ［13］ Zhang T, Wang K, Zhang J, et al. Huaier aqueous extract inhibits colorectal cancer stem cell growth partially via downregulation of the Wnt/βcatenin pathway［J］. Oncol Lett, 2013, 5(4): 11711176. DOI: 10.3892/ol.2013.1145. ［14］ Gong A, Huang S. FoxM1 and Wnt/βcatenin signaling in glioma stem cells［J］. Cancer Res, 2012, 72(22): 5658-5662. DOI: 10.1158/00085472.CAN-12-0953. ［15］ Sandberg CJ, Altschuler G, Jeong J, et al. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt signaling and a fingerprint associated with clinical outcome［J］. Exp Cell Res, 2013, 319(14): 22302243. DOI: 10.1016/j.yexcr.2013.06.004. ［16］ Kim KH, Seol HJ, Kim EH, et al. Wnt/βcatenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells［J］. Neuro Oncol, 2013, 15(2): 161-171. DOI: 10.1093/neuonc/nos299. ［17］ Rathod SS, Rani SB, Khan M, et al. Tumor suppressive miRNA34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways［J］. FEBS Open Bio, 2014, 4: 485-495. DOI: 10.1016/j.fob.2014.05.002. ［18］ Chen W, Zhang YW, Li Y, et al. Constitutive expression of Wnt/βcatenin target genes promotes proliferation and invasion of liver cancer stem cells［J］. Mol Med Rep, 2016, 13(4): 3466-3474. DOI: 10.3892/mmr.2016.4986. ［19］ Wang Y, He L, Du Y, et al. The long noncoding RNA lncTCF7 promotes selfrenewal of human liver cancer stem cells through activation of Wnt signaling［J］. Cell Stem Cell, 2015, 16(4): 413-425. DOI: 10.1016/j.stem.2015.03.003. ［20］ Gedaly R, Galuppo R, Daily MF, et al. Targeting the Wnt/βcatenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535［J］. PLoS One, 2014, 9(6): e99272. DOI: 10.1371/journal.pone.0099272. ［21］ Galuppo R, Maynard E, Shah M, et al. Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/βcatenin pathways［J］. Anticancer Res, 2014, 34(4): 1709-1713. ［22］ Zhang Y, Zhang X, Huang J, et al. Wnt signaling regulation of stemlike properties in human lung adenocarcinoma cell lines［J］. Med Oncol, 2015, 32(5): 157. DOI: 10.1007/s12032015-0596-9. ［23］ Yeh CT, Wu AT, Chang PM, et al. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer［J］. Am J Respir Crit Care Med, 2012, 186(11): 11801188. DOI: 10.1164/rccm.2012071180OC. ［24］ Fang L, Cai J, Chen B, et al. Aberrantly expressed miR5823p maintains lung cancer stem celllike traits by activating Wnt/βcatenin signalling［J］. Nat Commun, 2015, 6: 8640. DOI: 10.1038/ncomms9640. ［25］ Mao J, Fan S, Ma W, et al. Roles of Wnt/βcatenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment［J］. Cell Death Dis, 2014, 5: e1039. DOI: 10.1038/cddis.2013.515. ［26］ Lee SH, Koo BS, Kim JM, et al. Wnt/βcatenin signalling maintains selfrenewal and tumourigenicity of head and neck squamous cell carcinoma stemlike cells by activating Oct4［J］. J Pathol, 2014, 234(1): 99107. DOI: 10.1002/path.4383. ［27］ Hsieh IS, Chang KC, Tsai YT, et al. MicroRNA320 suppresses the stem celllike characteristics of prostate cancer cells by downregulating the Wnt/β-catenin signaling pathway［J］. Carcinogenesis, 2013, 34(3): 530538. DOI: 10.1093/carcin/bgs371. ［28］ Ono M, Yin P, Navarro A, et al. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth［J］. Proc Natl Acad Sci USA, 2013, 110(42): 1705317058. DOI: 10.1073/pnas.1313650110. ［29］ Wu G, Liu A, Zhu J, et al. MiR1207 overexpression promotes cancer stem celllike traits in ovarian cancer by activating the Wnt/βcatenin signaling pathway［J］. Oncotarget, 2015, 6(30): 28882-28894. DOI: 10.18632/oncotarget.4921. ［30］ Lin LC, Yeh CT, Kuo CC, et al. Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/βcatenin function［J］. J Agric Food Chem, 2012, 60(28): 7031-7039. DOI: 10.1021/jf301981n.

[1]	钱晓涛, 石子宜, 胡格, 吴晓维.Ⅲ~ⅣA期食管鳞状细胞癌放化疗后行巩固化疗的疗效：一项真实世界临床研究[J]. 国际肿瘤学杂志, 2024, 51(6): 326-331.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[4]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[5]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[6]	王培鑫, 赵军, 徐世红, 姜朝阳, 王小强, 杨红娟.铁死亡相关机制在骨肉瘤中的应用进展[J]. 国际肿瘤学杂志, 2024, 51(5): 308-311.
[7]	王昆, 周中新, 臧其威.血清TGF-β1、VEGF水平对非小细胞肺癌患者单孔胸腔镜根治术后复发的预测价值[J]. 国际肿瘤学杂志, 2024, 51(4): 198-203.
[8]	萨蔷, 徐航程, 王佳玉.乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234.
[9]	杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙.肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238.
[10]	王子豪, 王宇, 杨鑫, 何艺, 莫兴奎, 袁涛.铁死亡在骨肉瘤中的分子机制及相关治疗的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 239-244.
[11]	张栋岩, 王品, 魏秋亚, 邓成伍, 魏相相, 高远飞, 王琛.索凡替尼靶向联合卡培他滨和奥沙利铂治疗肝内胆管癌术后患者1例及文献复习[J]. 国际肿瘤学杂志, 2024, 51(4): 249-253.
[12]	严爱婷, 王翠竹, 刘春桂, 鲁小敏.卡瑞利珠单抗与信迪利单抗治疗晚期非小细胞肺癌的临床疗效及安全性分析[J]. 国际肿瘤学杂志, 2024, 51(3): 137-142.
[13]	彭琴, 蔡玉婷, 王伟.KPNA2在肝癌中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 181-185.
[14]	岳红云, 张百红.肿瘤的分化治疗[J]. 国际肿瘤学杂志, 2024, 51(2): 109-113.
[15]	姜溪, 武永存, 梁艳, 楚丽, 段颖欣, 王力军, 霍俊杰.派安普利单抗联合化疗对晚期非小细胞肺癌患者血管生成及循环内皮细胞的影响[J]. 国际肿瘤学杂志, 2024, 51(2): 89-94.